Sensing Insulin Deterioration

Abstract

Type-1 and type-2 diabetes is an affliction affecting 371 million people worldwide. To manage this disease, patients use insulin to lower their blood sugar levels. However, patients are unable to sense if their insulin has become deteriorated without sending the substance back to the manufacturer, adding costs to the manufacturer and patient. A spectrophotometer machine will evaluate insulin samples at specific wavelengths to demonstrate deterioration. A high performance liquid chromatography machine will then check these same insulin samples’ potency. These machines will be utilized in parallel to determine if they can effectively determine if an insulin sample is deteriorated.